Intraocular Lens Market Size, Share, Analysis Forecast to 2028
Intraocular Lens (IOL) Market by Top Key Players are Alcon, Johnson & Johnson Services, Inc., Bausch & Lomb Incorporated, HOYA Corporation
Start typing here! You can add more paragraphs, images, videos, and more by clicking the icons in the toolbar!
The global intraocular lens (IOL) market size is projected to reach USD 5,318.8 million by 2026, thereby exhibiting a CAGR of 6.8% during the forecast period. However, the market was worth USD 3,159.3 million in 2018. This information is published in a recent report by Fortune Business Insights™, titled, “Intraocular Lens (IOL) Market Size, Share & Industry Analysis, By Type [Monofocal Intraocular Lens and Premium Intraocular Lens (Multifocal Intraocular Lens, Toric Intraocular Lens, and Others)], By Material [Polymethylmethacrylate (PMMA) and Foldable (Hydrophobic Acrylic, Hydrophilic Acrylic, and Silicone & Collamer)], By End User (Hospitals & Ambulatory Surgery Centers, Specialty Clinics, and Academic & Research Institutes) and Regional Forecast, 2019-2026.” The report further states that the market is set to gain impetus from the rising number of NGOs offering free cataract surgeries and eye examinations.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/intraocular-lens-market-101220
Fortune Business Insights™ lists out some of the most renowned organizations operating in the intraocular lens market. They are as follows:
Johnson & Johnson Services, Inc.
Bausch & Lomb Incorporated
Rayner Intraocular Lenses Limited
Other key market players
Monofocal IOL Segment to Lead Stoked by Favorable Government Reimbursement Policies
By type, the market is grouped into premium intraocular lens and monofocal intraocular lens. Amongst these, the monofocal intraocular lens is expected to lead by gaining the maximum IOL market share in the coming years. This growth is attributable to the rising number of favorable government reimbursement policies as well as cost-effective nature.